Related Experiment Video
Updated: Jun 10, 2026
10:20
In vitro Measurements of Tracheal Constriction Using Mice
Published on: June 25, 2012
Cholinergic effects on esophageal transit and clearance
Gastroenterology
|November 1, 1981
Summary
Esophageal contraction amplitudes, not frequency, are key for efficient esophageal emptying. Cholinergic stimulation improved function in reflux patients, while blockade impaired it in healthy subjects.
Area of Science:
- Gastroenterology
- Physiology
Background:
- Gastroesophageal reflux disease (GERD) is associated with impaired esophageal motility.
- Understanding the relationship between esophageal contractions and clearance is crucial for GERD management.
Purpose of the Study:
- To investigate the relationship between esophageal contractions and esophageal transit/clearance.
- To evaluate the effects of cholinergic stimulation (bethanechol) and blockade (atropine) on esophageal function in normal subjects and GERD patients.
Main Methods:
- Utilized modern manometric and scintigraphic techniques.
- Administered bethanechol and atropine sulfate to 20 normal subjects and 13 GERD patients.
- Assessed esophageal contraction amplitudes, propagation velocities, transit, and clearance.
Main Results:
- Bethanechol increased contraction amplitudes but decreased velocities; improved transit and clearance in GERD patients.
- Atropine decreased contraction amplitudes, increased velocities, and delayed transit/clearance.
- GERD patients exhibited diminished transit, clearance, and lower contraction amplitudes compared to normal subjects.
- Neither drug affected the incidence of deglutition-induced contractions.
Conclusions:
- Esophageal emptying efficiency is primarily determined by the amplitudes of esophageal contractions.
- Pharmacological modulation of cholinergic activity impacts esophageal motility and clearance, offering potential therapeutic insights for GERD.
Related Concept Videos
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:28Cholinergic Antagonists: Pharmacological Actions
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
01:27Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...